Summary of Classification and Labelling
General Information
EC / List no.
|
Name |
CAS Number
|
|---|---|---|
| 201-369-2 | N-(4-amino-9,10-dihydro-3-methoxy-9,10-dioxo-1-anthryl)-4-methylbenzenesulphonamide | 81-68-5 |
Notified classification and labelling according to CLP criteria
| Classification | Labelling | Specific Concentration limits, M-Factors | Notes | Classification affected by Impurities / Additives
|
Additional Notified Information
|
Number of Notifiers
|
Joint Entries
|
||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hazard Class and Category Code(s) | Hazard Statement Code(s) | Hazard Statement Code(s) | Supplementary Hazard Statement Code(s) | Pictograms, Signal Word Code(s) | |||||||
| STOT RE 2 | H373 (blood) (oral) | H373 |
GHS08 GHS09 Wng |
State/Form
|
4 |  |
View details | ||||
| Aquatic Chronic 2 | H411 | H411 | |||||||||
| Not Classified | 40 | ||||||||||
| STOT RE 2 | H373 (Blood) (oral) | H373 |
GHS08 GHS09 Wng |
2 | View details | ||||||
| Aquatic Chronic 2 | H411 | H411 | |||||||||
| H302+H312+H332 |
GHS07 Wng |
State/Form
|
1 | View details | |||||||
| H315 | |||||||||||
| H319 | |||||||||||
| H335 | |||||||||||
| STOT RE 2 | H373 (blood) (oral) | H373 |
GHS08 GHS09 Wng |
1 | View details | ||||||
| STOT RE 2 | H373 (Blood) (oral) | H373 | |||||||||
| Aquatic Chronic 2 | H411 | H411 | |||||||||
Number of Aggregated Notifications: 5